Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics Statistics

Total Valuation

ACRV has a market cap or net worth of $54.73 million. The enterprise value is -$78.48 million.

Market Cap	54.73M
Enterprise Value	-78.48M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ACRV has 31.46 million shares outstanding. The number of shares has increased by 48.59% in one year.

Current Share Class	31.46M
Shares Outstanding	31.46M
Shares Change (YoY)	+48.59%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	7.68%
Owned by Institutions (%)	29.60%
Float	16.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.31, with a Debt / Equity ratio of 0.02.

Current Ratio	10.31
Quick Ratio	10.23
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.87% and return on invested capital (ROIC) is -32.19%.

Return on Equity (ROE)	-47.87%
Return on Assets (ROA)	-30.32%
Return on Invested Capital (ROIC)	-32.19%
Return on Capital Employed (ROCE)	-65.04%
Revenue Per Employee	n/a
Profits Per Employee	-$1.10M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.72% in the last 52 weeks. The beta is 1.82, so ACRV's price volatility has been higher than the market average.

Beta (5Y)	1.82
52-Week Price Change	-75.72%
50-Day Moving Average	1.52
200-Day Moving Average	2.72
Relative Strength Index (RSI)	54.50
Average Volume (20 Days)	521,232

Short Selling Information

The latest short interest is 1.15 million, so 3.66% of the outstanding shares have been sold short.

Short Interest	1.15M
Short Previous Month	1.28M
Short % of Shares Out	3.66%
Short % of Float	6.90%
Short Ratio (days to cover)	0.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-94.41M
Pretax Income	-85.96M
Net Income	-85.96M
EBITDA	-93.21M
EBIT	-94.41M
Earnings Per Share (EPS)	-$2.24

Balance Sheet

The company has $137.42 million in cash and $3.26 million in debt, giving a net cash position of $134.16 million or $4.27 per share.

Cash & Cash Equivalents	137.42M
Total Debt	3.26M
Net Cash	134.16M
Net Cash Per Share	$4.27
Equity (Book Value)	143.04M
Book Value Per Share	4.55
Working Capital	124.98M

Cash Flow

In the last 12 months, operating cash flow was -$70.83 million and capital expenditures -$2.37 million, giving a free cash flow of -$73.20 million.

Operating Cash Flow	-70.83M
Capital Expenditures	-2.37M
Free Cash Flow	-73.20M
FCF Per Share	-$2.33

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.59%
Shareholder Yield	-48.59%
Earnings Yield	-154.39%
FCF Yield	-131.46%

Analyst Forecast

The average price target for ACRV is $17.75, which is 920.12% higher than the current price. The consensus rating is "Buy".

Price Target	$17.75
Price Target Difference	920.12%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1